• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Dissecting the expression landscape of mitochondrial genes in lung squamous cell carcinoma and lung adenocarcinoma.剖析肺鳞状细胞癌和肺腺癌中线粒体基因的表达格局。
Oncol Lett. 2018 Sep;16(3):3992-4000. doi: 10.3892/ol.2018.9113. Epub 2018 Jul 10.
2
Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.基于癌症干性的肺腺癌和肺鳞癌预后免疫相关基因特征。
Front Endocrinol (Lausanne). 2021 Oct 21;12:755805. doi: 10.3389/fendo.2021.755805. eCollection 2021.
3
Identification of the key genes and characterizations of Tumor Immune Microenvironment in Lung Adenocarcinoma (LUAD) and Lung Squamous Cell Carcinoma (LUSC).肺腺癌(LUAD)和肺鳞状细胞癌(LUSC)中关键基因的鉴定及肿瘤免疫微环境的特征分析
J Cancer. 2020 Jun 16;11(17):4965-4979. doi: 10.7150/jca.42531. eCollection 2020.
4
Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.肺腺癌和肺鳞状细胞癌风险组之间基因组和转录组差异的综合分析
J Pers Med. 2021 Feb 23;11(2):154. doi: 10.3390/jpm11020154.
5
System analysis of in LUAD and LUSC: The expression, prognosis, gene regulation network, and regulation targets.肺腺癌(LUAD)和肺鳞癌(LUSC)中 的系统分析:表达、预后、基因调控网络和调控靶点。
Int J Biol Markers. 2022 Jun;37(2):158-169. doi: 10.1177/03936155221084056. Epub 2022 Mar 7.
6
LINC00628 is differentially expressed between lung adenocarcinoma and squamous cell carcinoma and is associated with the prognosis of NSCLC.LINC00628在肺腺癌和肺鳞癌之间存在差异表达,并且与非小细胞肺癌的预后相关。
Oncol Lett. 2022 Feb;23(2):55. doi: 10.3892/ol.2021.13173. Epub 2021 Dec 21.
7
Use of four genes in exosomes as biomarkers for the identification of lung adenocarcinoma and lung squamous cell carcinoma.外泌体中四种基因作为鉴定肺腺癌和肺鳞癌生物标志物的应用。
Oncol Lett. 2021 Apr;21(4):249. doi: 10.3892/ol.2021.12510. Epub 2021 Feb 3.
8
Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.肺腺癌和肺鳞状细胞癌中免疫相关基因特征的鉴定
Front Immunol. 2021 Nov 23;12:752643. doi: 10.3389/fimmu.2021.752643. eCollection 2021.
9
[Identification of differentially expressed genes between lung adenocarcinoma and squamous cell carcinoma using transcriber signature analysis].[利用转录特征分析鉴定肺腺癌与肺鳞癌之间的差异表达基因]
Nan Fang Yi Ke Da Xue Xue Bao. 2019 Jun 30;39(6):641-649. doi: 10.12122/j.issn.1673-4254.2019.06.03.
10
High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.ECT2高表达是非小细胞肺腺癌总生存期和无复发生存期较差的独立预后因素。
PLoS One. 2017 Oct 31;12(10):e0187356. doi: 10.1371/journal.pone.0187356. eCollection 2017.

引用本文的文献

1
Mitochondria transcription and cancer.线粒体转录与癌症。
Cell Death Discov. 2024 Apr 8;10(1):168. doi: 10.1038/s41420-024-01926-3.
2
Functional Role of Mitochondrial DNA in Cancer Progression.线粒体 DNA 在癌症进展中的功能作用。
Int J Mol Sci. 2022 Jan 31;23(3):1659. doi: 10.3390/ijms23031659.
3
LINC00628 is differentially expressed between lung adenocarcinoma and squamous cell carcinoma and is associated with the prognosis of NSCLC.LINC00628在肺腺癌和肺鳞癌之间存在差异表达,并且与非小细胞肺癌的预后相关。
Oncol Lett. 2022 Feb;23(2):55. doi: 10.3892/ol.2021.13173. Epub 2021 Dec 21.
4
Mitochondrial DNA variation and cancer.线粒体 DNA 变异与癌症。
Nat Rev Cancer. 2021 Jul;21(7):431-445. doi: 10.1038/s41568-021-00358-w. Epub 2021 May 27.
5
Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma.完全切除的病理 IIIA-N2 期非小细胞肺癌患者的术后放疗:鳞状细胞癌的优势获益。
Radiol Oncol. 2020 Dec 3;55(1):66-76. doi: 10.2478/raon-2020-0070.

本文引用的文献

1
Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers.人类癌症代谢表达亚型的分子特征及临床意义
Cell Rep. 2018 Apr 3;23(1):255-269.e4. doi: 10.1016/j.celrep.2018.03.077.
2
Association of predicted pathogenic mutations in mitochondrial ND genes with distant metastasis in NSCLC and colon cancer.线粒体 ND 基因中预测的致病性突变与 NSCLC 和结肠癌的远处转移相关。
Sci Rep. 2017 Nov 14;7(1):15535. doi: 10.1038/s41598-017-15592-2.
3
Quantitative proteomics in lung cancer.肺癌中的定量蛋白质组学
J Biomed Sci. 2017 Jun 14;24(1):37. doi: 10.1186/s12929-017-0343-y.
4
Mitochondrial ND5 mutation mediated elevated ROS regulates apoptotic pathway epigenetically in a P53 dependent manner for generating pro-cancerous phenotypes.线粒体ND5突变介导的活性氧升高以P53依赖的方式表观遗传调控凋亡途径,从而产生促癌表型。
Mitochondrion. 2017 Jul;35:35-43. doi: 10.1016/j.mito.2017.05.001. Epub 2017 May 11.
5
Integrated genomic analysis of mitochondrial RNA processing in human cancers.人类癌症中线粒体RNA加工的综合基因组分析。
Genome Med. 2017 Apr 18;9(1):36. doi: 10.1186/s13073-017-0426-0.
6
Regulation of Mammalian Mitochondrial Gene Expression: Recent Advances.哺乳动物线粒体基因表达的调控:最新进展
Trends Biochem Sci. 2017 Aug;42(8):625-639. doi: 10.1016/j.tibs.2017.02.003. Epub 2017 Mar 9.
7
Mitochondrial respiratory gene expression is suppressed in many cancers.线粒体呼吸基因表达在许多癌症中受到抑制。
Elife. 2017 Jan 18;6:e21592. doi: 10.7554/eLife.21592.
8
LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.长链非编码RNA在肺鳞状细胞癌和肺腺癌中发生改变。
Oncotarget. 2017 Apr 11;8(15):24275-24291. doi: 10.18632/oncotarget.13651.
9
KEGG: new perspectives on genomes, pathways, diseases and drugs.京都基因与基因组百科全书(KEGG):关于基因组、通路、疾病和药物的新视角。
Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361. doi: 10.1093/nar/gkw1092. Epub 2016 Nov 28.
10
Expansion of the Gene Ontology knowledgebase and resources.基因本体知识库及资源的扩展。
Nucleic Acids Res. 2017 Jan 4;45(D1):D331-D338. doi: 10.1093/nar/gkw1108. Epub 2016 Nov 29.

剖析肺鳞状细胞癌和肺腺癌中线粒体基因的表达格局。

Dissecting the expression landscape of mitochondrial genes in lung squamous cell carcinoma and lung adenocarcinoma.

作者信息

Li Nan, Zhao Jing, Ma Yibing, Roy Bhaskar, Liu Ren, Kristiansen Karsten, Gao Qiang

机构信息

Laboratory of Molecular Medicine, Medical College, Eastern Liaoning University, Dandong, Liaoning 118003, P.R. China.

BGI Genomics, BGI-Shenzhen, Yantian, Shenzhen, Guangdong 518083, P.R. China.

出版信息

Oncol Lett. 2018 Sep;16(3):3992-4000. doi: 10.3892/ol.2018.9113. Epub 2018 Jul 10.

DOI:10.3892/ol.2018.9113
PMID:30128019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6096099/
Abstract

Lung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD) are the two major subtypes of lung cancer. To explore mitochondrial respiratory gene expression profiles in LUSC and LUAD, RNA sequencing data from The Cancer Genome Atlas was used for comprehensive analyses to establish the molecular characteristics of LUSC and LUAD. To elucidate expression profiles, subtypes were defined using unsupervised clustering of mitochondrial gene expression data. Differences in nuclear gene expression levels, signaling pathways and tumor microenvironments between subtypes were investigated. The analysis revealed that mitochondrial respiratory genes were generally expressed at lower levels in tumor tissues compared with matched control tissues. The expression of mitochondrially encoded NADH dehydrogenase 5 or 6 was associated with tumor progression in LUAD and LUSC. Patients were clustered into three subgroups based on the expression profile of 13 mitochondrial protein-encoding genes, and patients in Cluster 3 exhibited poor survival rates compared with patients from Cluster 1. Furthermore, this association was also observed in another independent data set. Further analyses of the expression of nuclear-encoded genes in the three clusters revealed the enrichment of several cancer-associated signaling pathways in Cluster 3, particularly the apoptotic signaling pathway, suggesting a potential association between the decreased expression of mitochondrial DNA genes and increased tumor aggressiveness. Furthermore, the analyses of immune cell compositions in the tumor microenvironment detected a significant increase in the proportion of CD4 T cells and a decrease in the proportion of macrophages in LUAD compared with LUSC (P=0.0000104 and P=0.0000105, respectively). In conclusion, the present study revealed an association between the expression patterns of mitochondrial-encoded genes and lung cancer, which may contribute to novel therapeutic strategies for patients with LUSC and LUAD.

摘要

肺鳞状细胞癌(LUSC)和肺腺癌(LUAD)是肺癌的两种主要亚型。为了探究LUSC和LUAD中线粒体呼吸基因的表达谱,利用来自癌症基因组图谱的RNA测序数据进行综合分析,以确定LUSC和LUAD的分子特征。为了阐明表达谱,使用线粒体基因表达数据的无监督聚类来定义亚型。研究了各亚型之间核基因表达水平、信号通路和肿瘤微环境的差异。分析显示,与匹配的对照组织相比,肿瘤组织中线粒体呼吸基因的表达水平通常较低。线粒体编码的NADH脱氢酶5或6的表达与LUAD和LUSC中的肿瘤进展相关。根据13个线粒体蛋白编码基因的表达谱将患者分为三个亚组,与第1组患者相比,第3组患者的生存率较差。此外,在另一个独立数据集中也观察到了这种关联。对三个亚组中核编码基因表达的进一步分析揭示了第3组中几种癌症相关信号通路的富集,特别是凋亡信号通路,这表明线粒体DNA基因表达降低与肿瘤侵袭性增加之间可能存在关联。此外,对肿瘤微环境中免疫细胞组成的分析发现,与LUSC相比,LUAD中CD4 T细胞比例显著增加,巨噬细胞比例降低(分别为P = 0.0000104和P = 0.0000105)。总之,本研究揭示了线粒体编码基因的表达模式与肺癌之间的关联,这可能有助于为LUSC和LUAD患者制定新的治疗策略。